RxDoctor Payments Data

Michael Shin, MD

Emergency Medicine · Minneapolis, MNNPI 1720234180

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,456 of the $3,206 with a category attached, or 76.6%. 9 manufacturers reported payments, led by Smith+Nephew at 57.9% of the total. Reporting peaked in 2021 at $860 and has fallen 85.7% since, to $123 in 2025. Among emergency medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,206in general payments, 2019–2025

Across 31 payments — averaging $103.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Organogenesis Inc.$793
  • Abbott$122
  • Kerecis Limited$119
  • KCI USA, Inc.$97
  • Stability Biologics, LLC$96
  • plus $123 from 3 others

What the payments were for

  • Speaking & faculty fees$75023%
  • Food & beverage$2,45677%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,206 in reported general payments places this provider in the 95th percentile of 1,017 emergency medicine providers in Minnesota.

See all emergency medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$46,937
Medicare patients
185
Services billed
635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DescovyEmtricitabine/Tenofov Alafenam243$492,108
Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf)64$2,595
Ondansetron Hcl80$538
Doxycycline Hyclate15$153

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →